Radiofrequency ablation of pulmonary tumors

European Journal of Radiology

Volumn 75, Issue 1, 2010, Pages 23-27

  Crocetti, Laura ^a   Lencioni, Riccardo ^a  

^a Department of Liver Transplants Hepatology and Infectious Diseases   (Italy)

Author keywords

Ablation; Lung cancer; Radiofrequency; Solid tumor; Therapy

Indexed keywords

ABLATION THERAPY; COLORECTAL CANCER; HEPATOCELLULAR CARCINOMA; HIGH-RISK INDIVIDUALS; IMAGE-GUIDED; LIVER TRANSPLANTATION; LOCAL TUMOR ABLATION; LUNG CANCER; LUNG METASTASIS; MEDICALLY INOPERABLE; METASTATIC DISEASE; NON SMALL CELL LUNG CANCER; RADIO FREQUENCIES; RADIOFREQUENCY ABLATION; SOLID TUMOR; SOLID TUMORS; SURGICAL RESECTION; SURVIVAL RATE;

BIOLOGICAL ORGANS; CHEMOTHERAPY; DISEASE CONTROL; RADIOTHERAPY; TRANSPLANTATION (SURGICAL); TUMORS;

ABLATION;

ANTINEOPLASTIC AGENT;

ANESTHESIOLOGY; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; COLORECTAL CANCER; EXTERNAL BEAM RADIOTHERAPY; HEMOPTYSIS; HIGH RISK PATIENT; HUMAN; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MONITORING; OUTCOME ASSESSMENT; PLEURA EFFUSION; PNEUMOTHORAX; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SUBCUTANEOUS EMPHYSEMA; SURVIVAL RATE; TREATMENT CONTRAINDICATION; TUMOR SEEDING;

CATHETER ABLATION; HUMANS; LUNG NEOPLASMS; SURGERY, COMPUTER-ASSISTED;

EID: 77953873273     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2010.04.011     Document Type: Article

References (53)

1. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
2. Crocetti L., DeBaere T., and Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol 33 (2010) 11-17
3. Lencioni R., Crocetti L., Pina M.C., et al. Percutaneous image-guided radiofrequency ablation of liver tumors. Abdom Imaging 34 (2009) 547-556
4. Lencioni R., Crocetti L., Cioni R., et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 9 (2008) 621-628
5. Yamakado K., Inoue Y., Takao M., et al. Long-term results of radiofrequency ablation in colorectal lung metastases: single center experience. Oncol Rep 22 (2009) 885-891
6. Lanuti M., Sharma A., Digumarthy S.R., et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 137 (2009) 160-166
7. D'Addario G., Felip E., and ESMO Guidelines Working Group. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19 Suppl. 2 (2008) ii39-ii40
8. Scott W.J., Howington J., Feigenberg S., Movsas B., and Pisters K. American College of Chest Physicians. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132 (2007) 234S-242S
9. Raz D.J., Zell J.A., Ou S.H., et al. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 132 (2007) 193-199
10. McGarry R.C., Song G., des Rosiers P., and Timmerman R. Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest 121 (2002) 1155-1158
11. Wisnivesky J.P., Bonomi M., Henschke C., et al. Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest 128 (2005) 1461-1467
12. Qiao X., Tullgren O., Lax I., et al. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 41 (2003) 1-11
13. Fernando H.C., Hoyos A.D., Litle V., Belani C.P., and Luketich J.D. Radiofrequency ablation: identification of the ideal patient. Clin Lung Cancer 6 (2004) 149-153
14. McCormack P.M., and Ginsberg R.J. Current management of colorectal metastases to the lung. Chest Surg Clin North Am 8 (1998) 119-126
15. Weiser M.R., Downey R.J., Leung D.H., and Brennan M.F. Repeat resection of pulmonary metastases on patients with soft tissue sarcoma. J Am Coll Surg 191 (2000) 184-190
16. Shu Yan Huo A., Lawson Morris D., King J., and Glenn D. Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma. Ann Surg Oncol 16 (2009) 3169-3175
17. Nakamura T., Matsumine A., Yamakado K., et al. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas. Cancer 115 (2009) 3774-3781
18. Hiraki T., Gobara H., Mimura H., et al. Does tumor type affect local control by radiofrequency ablation in the lungs?. Eur J Radiol 74 (2010) 136-141
19. de Baère T., Palussière J., Aupérin A., et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 240 (2006) 587-596
20. Ambrogi M.C., Fanucchi O., Lencioni R., Cioni R., and Mussi A. Pulmonary radiofrequency ablation in a single lung patient. Thorax 61 (2006) 828-829
21. Iguchi T., Hiraki T., Gobara H., et al. Percutaneous radiofrequency ablation of lung tumors close to the heart or aorta: evaluation of safety and effectiveness. J Vasc Interv Radiol 18 (2007) 733-740
22. Fernando H.C. Radiofrequency ablation to treat non-small cell lung cancer and pulmonary metastases. Ann Thorac Surg 85 (2008) S780-S784
23. Van Cutsem E.J., Oliveira J., and ESMO Guidelines Working Group. Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19 Suppl. 2 (2008) ii33-ii34
24. Hiraki T., Tajiri N., Mimura H., et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology 241 (2006) 275-283
25. Yasui K., Kanazawa S., Sano Y., et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology 231 (2004) 850-857
26. Sano Y., Kanazawa S., Gobara H., et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer 109 (2007) 1397-1405
27. YamagamiT, KatoT, HirotaT, et al. Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms. J Vasc Interv Radiol 17 (2006) 1625-1629
28. Gillams A.R., and Lees W.R. Analysis of the factors associated with radiofrequency ablation-induced pneumothorax. Clin Radiol 62 (2007) 639-644
29. Hoffmann R.T., Jakobs T.F., Lubienski A., et al. Percutaneous radiofrequency ablation of pulmonary tumors. Is there a difference between treatment under general anaesthesia and under conscious sedation?. Eur J Radiol 59 (2006) 168-174
30. Lencioni R., Crocetti L., Cioni R., et al. Radiofrequency ablation of lung malignancies: where do we stand?. Cardiovasc Intervent Radiol 27 (2004) 581-590
31. Crocetti L., Lencioni R., Bozzi E., Sbrana A., and Bartolozzi C. Lung radiofrequency ablation: in vivo experimental study with low-perfusion-rate multitined electrodes. Cardiovasc Intervent Radiol 31 (2008) 610-618
32. Anderson E.M., Lees W.R., and Gillams A.R. Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Intervent Radiol 32 (2009) 478-483
33. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
34. Fernando H.C., De Hoyos A., Landreneau R.J., et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 129 (2005) 639-644
35. Beland M.D., Wasser E.J., Mayo-Smith W.W., and Dupuy D.E. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology 254 (2010) 301-307
36. Simon C.J., Dupuy D.E., DiPetrillo T.A., et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243 (2007) 268-275
37. Lee J.M., Jin G.Y., Goldberg S.N., et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 230 (2004) 125-134
38. Pennathur A., Luketich J.D., Abbas g, et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg 134 (2007) 857-864
39. Hiraki T., Sakurai J., Tsuda T., et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors. Cancer 107 (2006) 2873-2880
40. Dupuy D.E., DiPetrillo T., Gandhi S., et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 129 (2006) 738-745
41. Grieco C.A., Simon C.J., Mayo-Smith W.W., DiPetrillo T.A., Ready N.E., and Dupuy D.E. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol 17 (2006) 1117-1124
42. Yan T.D., King J., Sjarif A., Glenn D., Steinke K., and Morris D.L. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 13 (2006) 1529-1537
43. Yamakado K., Hase S., Matsuoka T., et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 18 (2007) 393-398
44. Hiraki T., Gobara H., Iishi T., et al. Percutaneous radiofrequency ablation for pulmonary metastases from colorectal cancer: midterm results in 27 patients. J Vasc Interv Radiol 18 (2007) 1264-1269
45. Pfannschmidt J., Muley T., Hoffmann H., and Dienemann H. Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg 126 (2003) 732-739
46. Saito Y., Omiya H., Kohno K., et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg 124 (2002) 1007-1013
47. McCormack P.M., Bains M.S., Begg C.B., et al. Role of videoassisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. Ann Thorac Surg 62 (1996) 213-216
48. Mutsaerts E.L., Zoetmulder F.A., Meijer S., Baas P., Hart A.A., and Rutgers E.J. Long-term survival of thoracoscopic metastasectomy vs metastasectomy by thoracotomy in patients with a solitary pulmonary lesion. Eur J Surg Oncol 28 (2002) 864-868
49. Steinke K., Sewell P.E., Dupuy D., et al. Pulmonary radiofrequency ablation-an international study survey. Anticancer Res 24 (2004) 339-343
50. Okuma T., Matsuoka T., Yamamoto A., et al. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Intervent Radiol 31 (2008) 122-130
51. Covey A.M., Gandhi R., Brody L.A., et al. Factors associated with pneumothorax and pneumothorax requiring treatment after percutaneous lung biopsy in 443 consecutive patients. J Vasc Interv Radiol 15 (2004) 479-483
52. Hiraki T., Mimura H., Gobara H., et al. Two cases of needle-tract seeding after percutaneous < radiofrequency ablation for lung cancer. J Vasc Interv Radiol 20 (2009) 415-418
53. Yamakado K., Akeboshi M., Nakatsuka A., et al. Tumor seeding following lung radiofrequency ablation: a case report. Cardiovasc Intervent Radiol 28 (2005) 530-532